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Purpose: Congenital fibrosis of the extraocular muscles type I (CFEOM1), the most common CFEOM worldwide, is
characterized by bilateral ptotic hypotropia, an inability to supraduct above the horizontal midline, horizontal strabismus
(typically  exotropia),  and  ophthalmoplegia  with  abnormal  synkinesis.  This  distinct  non-syndromic  phenotype  is
considered autosomal dominant and is virtually always from heterozygous missense mutations in kinesin family member
21A (KIF21A). However, there are occasional KIF21A-negative cases, opening the possibility for a recessive cause. The
objective of this study is to explore this possibility by assessing CFEOM1 patients exclusively from consanguineous
families, who are the most likely to have recessive cause for their phenotype if a recessive cause exists.
Methods:  Ophthalmic  examination  and  candidate  gene  direct  sequencing  (KIF21A,  paired-like  homeobox  2A
[PHOX2A], tubulin beta-3 [TUBB3]) of CFEOM1 patients from consanguineous families referred for counseling from
2005 to 2010.
Results: All 5 probands had classic CFEOM1 as defined above. Three had siblings with CFEOM. None of the probands
had mutations in KIF21A, PHOX2A, or TUBB3.
Conclusions: The lack of KIF21A mutations in CFEOM1 patients exclusively from consanguineous families, most of
whom had siblings with CFEOM, is strong evidence for a recessive form of CFEOM1. Further studies of such families
will hopefully uncover the specific locus(loci).
Congenital fibrosis of the extraocular muscles type 1
(CFEOM1, OMIM 135700) is the most common form of
CFEOM  reported  worldwide  [1].  It  is  a  distinct  non-
syndromic congenital cranial dysinnervation disorder and is
characterized by bilateral ptotic hypotropia, an inability to
supraduct above the horizontal midline, horizontal strabismus
(typically  exotropia),  and  a  variable  degree  of
ophthalmoplegia  with  abnormal  synkinesis  [2-4].  The
phenotype was first mapped as an autosomal dominant fully
penetrant  trait  to  the  centromere  on  chromosome  12  [5].
Screening  of  transcripts  in  this  region  in  several  affected
families  lead  to  the  discovery  of  heterozygous  missense
mutations in kinesin family member 21A (KIF21A) as the
cause [2]. Since then further studies provide strong evidence
that the classic CFEOM1 phenotype results from mutations in
KIF21A and that sporadic cases are due to de novo mutations
in  the  same  gene  [1-3,6-14].  A  heterozygous  KIF21A
missense  mutation  has  been  found  to  underlie  CFEOM1
patients  across  populations  worldwide  with  most  patients
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having mutations in exon 21 that affect arginine at position
954 of the protein (p.R954W, p.R954Q, or p.R954L) [1-3]. It
has been suggested that methylation of CpG dinucleotides in
exon  21  of  KIF21A  increases  susceptibility  to  mutational
events [13]. Other than exon 21, only 2 other exons in the 38-
exon gene have been reported to harbor mutations: exon 8
(p.M356T)  and  exon  20  (p.E944Q,  p.M947V,  p.M947T,
p.M947R)  [3].  The  lack  of  mutations  in  other  exons  of
KIF21A and the lack of other types of mutations (other than
missense)  may  be  because  such  mutations  are  lethal  or
because they underlie a phenotype thus far not associated with
the gene. The normal function of the KIF21A protein includes
the transport of membranous organelles, protein complexes,
and  mRNAs  to  specific  destinations  within  the  cell  in  a
microtubule- and ATP-dependent manner. These functions
are essential for normal morphogenesis and functioning of the
cell [15]; however, missense KIF21A mutations only appear
to significantly affect the orbit, causing widespread orbital
dysinnervation [16].
Other clinical forms of CFEOM with a known genetic
basis are CFEOM2 (OMIM 602078) and CFEOM3 (OMIM
600638).  CFEOM2,  the  rarest  CFEOM  phenotype,  is  a
recessive  disorder  that  was  first  mapped  to  11q13  in
consanguineous families [17] and later found to be secondary
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218TABLE 1. PRIMERS FOR KIF21A.
Exon 5′ to 3′ primer sequence PCR conditions
Kfi21a_x1Fn ctgttggcttctccacagg 52 °C/35 cycles
Kfi21a_x1Rn gggactcactgcctcagttt  
Kfi21a_x2Fn tcatgattttgggggattgt 53 °C/35 cycles
Kfi21a_x2Rn caaaaatgaaagcgcaactg  
Kif21a_x3F tcagttgcgctttcatttttg 53 °C/35 cycles
Kif21a_x3R ctccaacctgggtgacagaa  
Kif21a _x4F tagcctcattcattttaatgtgtt 59 °C/35 cycles
Kif21a _x4R gatcttaattccatgtcatgcttc  
Kif21a _x5F tgcctgtaactgaactaataatgtga 59 °C/35 cycles
Kif21a _x5R atggctgaccagcttcaact  
Kif21a _x6F tttggctttatgcctgtttc 59 °C/35 cycles
Kif21a _x6R tgaggagattggagattcagtg  
Kif21a_x7F cttatttctgtttcaaagaattagta 59 °C/35 cycles
Kif21a_x7R cctacacctcaagggatgct  
Kif21a _x8F caggggcttttaaatttgct 59 °C/35 cycles
Kif21a _x8R ctccaaaaggaaggaggaca  
Kif21a_x9Fn tggtcttgaactcctgacctc 59 °C/ 35 cycles
Kif21a_x9rn tgccctccagaagttaatcc  
Kif21a_x10F tgtggtctgctcatgtaataaagg 53 °C/35 cycles
Kif21a_x10R ggaatatgacatcaagggaaagg  
Kif21a_x11Fn ccacagagaaaaatgctcccta 59 °C/35 cycles
Kif21a_x11Rn tgaatggaatgcaaaagcag  
Kif21a _x12F gcatccaagcatgcctaatc 59 °C/35 cycles
Kif21a _x13R tttaggagcagcccagctta  
Kif21a_x13Fn tgattggcaatttccattttt 59 °C/35 cycles
Kif21a_x13Rn gactccccaacacaatgctt  
Kif21a _x14F gttggggagtcaggggtaga 56 °C/35 cycles
Kif21a _x14R taaagccttggaaggcaaatg  
Kif21a _x15F cattcaccttttggttgttgg 59 °C/35 cycles
Kif21a _x15R aggcacaaactttgacttgc  
Kif21a _x16F gacaccctagtcttctgagatgtg 59 °C/35 cycles
Kif21a _x16R ttgccaaaggaaattacatca  
Kif21a _x17F taaacgtgcagcaaaactgc 59 °C/35 cycles
Kif21a _x17R tgcttatctattgtccttaacctgc  
Kif21a x18F tggccgttaatactgaatgttg 56 °C/35cycles
Kif21a x18R aaagcaggttggattttaagaaa  
Kif21a_x19F ccatttggaagaaaccttctg 56 °C/35 cycles
Kif21a_x19R tgcactgccaaataatgagc  
Kif21a _x20–21F ggcaacaaatggaaacaggt 59 °C/35 cycles
Kif21a _x20–21R tggcatacatgtaaaacctaagc  
Kif21a _x22F ccctatgtttcttggggtaatgat 59 °C/35 cycles
Kif21a _x22R tccttattacaaagcaaagggtta  
Kif21a _x23–24F ttactggaggagctgggatg 59 °C/35 cycles
Kif21a _x23–24R tagtgtgtttgtgggcatgg  
Kif21a _x25_ 26F actaaaaccatcgtgcccat 59 °C/35 cycles
Kif21a _x25_ 26R gctttagtaaaaccatgccctc  
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219to homozygous mutations in the hindbrain transcription factor
paired-like  homeobox  2A  (PHOX2A)  [18].  PHOX2A
knockout animal models reveal that the gene is responsible
for development of the oculomotor and trochlear cranial nerve
nuclei [19,20]. The CFEOM2 phenotype is characterized by
bilateral  large-angle  exotropia,  ptosis,  miosis,  and
ophthalmoplegia with abnormal synkinesis [4,21]. CFEOM3
is CFEOM that does not meet the classic criteria for CFEOM1
or CFEOM2. CFEOM3 can be unilateral or bilateral, is often
autosomal dominant, and can have variable penetrance [4,
22,23].  A  family  with  autosomal  dominant  CFEOM  is
considered to be a CFEOM3 pedigree even if one or more
members has (have) classic CFEOM1 if at least one affected
family member does not meet the criteria for CFEOM1 [4,
23]. Most CFEOM3 families have mapped to 16qter [23-25]
and  are  due  to  heterozygous  mutation  in  tubulin  beta-3
TABLE 1. CONTINUED.
Exon 5′ to 3′ primer sequence PCR conditions
Kif21a 26F tggcctagtgaatagcacttagaa 59 °C/35 cycles
Kif21a 26R cagttaccacttaaagggaaatatga  
Kif21a _x27F cacacctaggaaaagacacgct 56 °C/35 cycles
Kif21a _x27R ggggagacaacacctagcaa  
Kif21a_x28F caagtaataatctttctgaggttcca 56 °C/35 cycles
Kif21a_x28R accacagcaccagcctaaat  
Kif21a _x29F ttgttcagaatgcattttatcttaca 59 °C/35 cycles
Kif21a _x29R gcatggttcctttcccatt  
Kif21a _x30F agcagggcactatgaaggaa 56 °C/35 cycles
Kif21a _x30R tttatctaaaaggtatgaccacaaaa  
Kif21a_x31Fn tgtctcattccctttcacca 56 °C/35 cycles
Kif21a_x31Rn caacagacttgatctgaaggaga  
Kif21a _x32F gcttaaaagagagcagtfctgga 59 °C/35 cycles
Kif21a _x32R ggttgaaccagattatccga  
Kif21a _x33F tgaagttaggatccttgtggtatg 59 °C/35 cycles
Kif21a _x33R tgggaagtggacaggtatacaa  
Kif21a _x34F tgtgttaggtgctgtgctagg 56 °C/35 cycles
Kif21a _x34R aaggacacaagagacatttagagg  
Kif21a _x35F gcccaagatcccatctctaa 56 °C/35 cycles
Kif21a _x35R ccactaactatgaatgaaggaaaaga  
Kif21a_x36Fn ctccagcctgggaaacatag 59 °C/35 cycles
Kif21a_x36Rn ggcctgattaatattatctgtaaatga  
Kif21a _x37F ctttctccagccaattccaa 59 °C/35cycles
Kif21a _x37R aacctggggtgcctaaattc  
Kif21a _x38F tgtaaagggcacatggtaacaa 59 °C/35 cycles
Kif21a _x38R gcagttgaattcagatatattttcca  
TABLE 2. PRIMERS FOR PHOX2A.
Exon 5′ to 3′ primer sequence PCR conditions
Phox2ax1.1Fn tccacacctctgagccctaagacgg 63 °C/DMSO10%
Phox2ax1.1Rn gccgcagggggctgtattggaagc  
Phox2ax1.2fn ccccgggccgatggactact 63 °C/DMSO10%
Phox2ax1.2Rn agcgggcccagggattc  
Phox2ax2fn tcactcccccatcctttttgc 57 °C/35 cycles
Phox2ax2Rn gctcccacacctccttcca  
Phox2ax3.1fn gatctcactcgagccttgc 57 °C/35 cycles
Phox2ax3.1Rn ctgcacgtggactccttgga  
Phox2ax3.2fn cgggccaagttccgcaaacaggag 57 °C/35 cycles
Phox2ax3.2Rn ggacgtctctgggggcaggctcgga  
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220(TUBB3), a gene involved in microtubule dynamics, kinesin
interactions, and axon guidance [22]. Unlike patients with
CFEOM1  or  CFEOM2,  patients  with  TUBB3-related
CFEOM3 can have extraorbital neurologic findings as well
[2].  In  some  instances,  CFEOM3  can  be  caused  by
heterozygous missense KIF21A mutations [23].
CFEOM1 is considered to be an autosomal dominant
fully penetrant condition. Although KIF21A is the only gene
associated with CFEOM1 to date, up to 40% of sporadic
CFEOM1  cases  do  not  have  identifiable  mutations  in
KIF21A [3]. Among the possibly genetic causes are mutations
in  a  KIF21A  promotor,  mutations  in  PHOX2A  and/or
TUBB3, or dominant or recessive mutations at a different
locus. If a recessive cause for CFEOM1 exists, one would
expect it to occur more commonly in CFEOM1 patients from
large consanguineous families [26]. In the current study, we
perform candidate gene testing in CFEOM1 patients from
consanguineous  families  to  explore  the  possibility  of  a
recessive cause for the CFEOM1 phenotype.
METHODS
Institutional board approval was granted for this study. Only
probands  with  CFEOM1  who  were  from  consanguineous
families were invited to participate in the study. Enrolled
patients, who had no known relationship to each other, had
complete orthoptic and ophthalmic examination as well as
5 ml venous blood sampling for candidate gene testing and
were referred to one of the authors (A.O.K.) from 2005 to
2010.  Cyclopentolate  1%  was  used  for  dilation  and
cycloplegic refraction. When affected relatives were available
and willing, they were examined as well. The candidate genes
KIF21A,  PHOX2A,  and  TUBB3  were  directly  sequenced.
Briefly, polymerase chair reaction products from all exons of
KIF21A  (NM_017641),  PHOX2A  (NM_005169),  and
TUBB3 (NM_006086.2) were sequenced using the ABI Prism
Big Dye Terminator v3.1 Cycle Sequencing Kit as described
by the manufacturer. Results were exported in one of several
formats for visualization and sequence was analyzed using
SeqMan 6.1 (Lasergene 6 software package) [22,27]. Primers
used for KIF21A are shown in Table 1, for PHOX2A are shown
in Table 2, and for TUBB3 are shown in Table 3 and are as
previously published [22].
RESULTS
Pedigrees for the 5 patients are shown in Figure 1. All 5
probands had classic CFEOM1 without pupillary abnormality
as defined above. One proband had an affected sibling with
CFEOM1 (family 3 in Figure 1) and 2 probands each had an
affected sibling with CFEOM3 (unilateral CFEOM ; families
4 and 5 in Figure 1). Clinical features of the probands are
summarized in Table 4 and the typical proband phenotype is
shown in Figure 2 (patient 1 from Table 4). No patient had
significant extra-orbital disease.
No proband had mutations or polymorphic variations in
KIF21A, PHOX2A, or TUBB3.
DISCUSSION
Five CFEOM1 probands from consanguineous families were
assessed in this study, none of whom had significant extra-
orbital disease. Two were sporadic cases, one had a sibling
with CFEOM1, and 2 each had a sibling with CFEOM3. No
proband  from  this  unique  CFEOM1  cohort  harbored
mutations in KIF21A, TUBB3, or PHOX2A. Rather than being
an autosomal dominant phenotype, CFEOM1 in our cohort
was almost certainly related to homozygous mutations in a
locus (or in loci) that to date has (or have) not been associated
with the condition.
The 3 previously-reported CFEOM1 families from Saudi
Arabia  were  not  consanguineous  and  all  harbored
heterozygous missense KIF21A mutations [6,9]. Two families
had autosomal dominant inheritance and both harbored the
TABLE 3. LIST OF PRIMERS FOR TUBB3.
Exon 5’ to 3’ sequence Product size Temperature/cycles
TUBB3X1F ggccgcggctataagag 272 56 °C /35
TUBB3X1R catccctttgttgcaggttc    
TUBB3X2F tgggtcaaaagccctaatttt 317 56 °C /35
TUBB3X2R ctgagagctggtgagtccag    
TUBB3X3F gctcttaggatgtgagcagga 323 56 °C /35
TUBB3X3R ggagctgaccattccttgtt    
TUBB3X4-1F atgagaaggggtgctcagtg 489 56 °C /35
TUBB3X4-1R ctcgttgtcgatgcagtagg    
TUBB3X4-2F cgcatcatgaacaccttcag 498 56 °C/35
TUBB3X4-2R gtccacctccttcatggaca    
TUBB3X4-3F agctcacccagcagatgttc 594 56 °C /35
TUBB3X4-3R gaggggaaagcagggtgt    
Sequences in Table are based on [22].
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221most  common  KIF21A  mutation  reported  worldwide,
p.R954W  [9].  The  third  family,  of  Jordanian  ancestry,
exhibited  apparent  autosomal  recessive  inheritance  with
atypical abnormal pupils but in fact harbored heterozygous
p.R954L KIF21A mutation with parental germline mosaicism
[6]. In the current series, none of the 5 CFEOM1 patients
harbored mutations in known CFEOM genes. Two cases were
sporadic and 3 had affected siblings. For one, the sibling also
had CFEOM1 (family 3 from Figure 1). For the other 2, the
each had an affected sibling with CFEOM3 (families 4 and 5
from Figure 1). These latter 2 families would be considered
by some authors as CFEOM3 pedigrees [4,23].
Studies of consanguineous families are more likely to
uncover recessive cause for a given phenotype if a recessive
cause  exists  because  of  parental  shared  recent  ancestry.
Although  every  individual  is  a  heterozygous  carrier  for
mutated alleles that would potentially cause recessive disease
in the homozygous (or compound heterozygous) state, it is
unlikely  that  the  individual's  spouse  will  carry  the  same
disorder  unless  they  are  related  [28].  Thus  studies  of
exclusively  consanguineous  families  with  a  specific
Figure 1. Pedigrees for the five CFEOM
probands (arrow indicates proband). All
individuals indicated as affected were
confirmed  to  be  affected  to  have
CFEOM  by  examination.  Question
mark indicates that the individual was
described as having strabismus but was
not  available  for  confirmatory
ophthalmic examination.
TABLE 4. SUMMARY OF CLINICAL FEATURES.




BCVA Primary AB/AD UP/DN CycloRef Comments
1 7 M 5 none 20/20 xt/hypo −4/-2 −6/-1 +0.50 attempt up=ad
          20/30 xt/hypo −4/-2 −6/-1 +0.50 attempt up=ad




20/40 xt/hypo −4/-2 −6/-1 +2.00–
2.75x015
attempt up=ad
        
  20/400 xt/hypo −4/-2 −6/-1 −5.00–
2.00x150
attempt up=ad
3 9 F 6 Younger
sister with
CFEOM1




       








20/30 et/hypo −2/0 −5/0 +2.00 attempt ab=dn;
attempt up=ad;
torsional nystagmus
       
  20/25 et/hypo −3/0 −5/0 +2.00 attempt up=ad;
torsional nystagmus




20/40 xt/hypo −2/-3 −5/-3 +2.00 attempt
up=dn&ad
       
  20/60 xt/hypo −2/-1 −5/-3 +8.00 attempt up=ab
        For each patient where relevant, first row represents right eye data and second row represents left eye data; AGE:age in years;
        F:female;  M:male;  BCVA:best-corrected  visual  acuity;  CSM:central  steady  maintained;  et:esotropia;  xt:exotropia;  hypo:
        hypotropia;ab/ad:limitation of abduction/adduction on a scale of 0 to −4 (−5=eye cannot reach primary); CycloRef:cycloplegic
        refraction; up/down:limitation of supraduction/infraduction on a scale of 0 to −4 (−5=eye cannot reach primary); attempted x=y:
        when x attempted, y inappropriately occurs (dysinnervation).
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222phenotype offer a unique opportunity to uncover a recessive
cause for the phenotype if a recessive cause exists. Our study
confirms the existence of recessive CFEOM1. There may be
one or more such loci, each of which may be a separate gene
or locus that regulates pathways in known genes associated
with CFEOM. Whether the 2 families that included a sibling
with CFEOM3 (families 4 and 5 from Figure 1) are considered
CFEOM3 families or families with CFEOM1 probands, the
observed phenotype is likely related to a recessive cause that
has not yet been described.
In  summary,  although  most  CFEOM1  is  due  to
heterozygous missense KIF21A mutations, there exists at least
one additional autosomal recessive cause for the phenotype.
This  information  is  useful  in  the  genetic  counseling  of
sporadic KIF21A-negative CFEOM1 patients. It is hoped that
further ascertainment and study of CFEOM1 patients from
consanguineous families will uncover the novel locus(loci).
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